Ardent Health (ARDT) Projected to Post Earnings on Tuesday

Key Points

• Ardent Health (ARDT) is expected to announce its Q2 2025 earnings on August 5th, with analysts predicting earnings of $0.51 per share and revenue of $1.54 billion.
• The company previously reported earnings of $0.29 EPS in Q1, surpassing estimates, and has set its FY 2025 guidance for EPS between 1.730-2.010.
• Analysts have a consensus rating of "Moderate Buy" for Ardent Health, with a target price of $20.30, despite recent downgrades by some institutions.

Ardent Health (NYSE:ARDT - Get Free Report) is expected to issue its Q2 2025 quarterly earnings data before the market opens on Tuesday, August 5th. Analysts expect the company to announce earnings of $0.51 per share and revenue of $1.54 billion for the quarter. Ardent Health has set its FY 2025 guidance at 1.730-2.010 EPS.

Ardent Health (NYSE:ARDT - Get Free Report) last released its quarterly earnings results on Tuesday, May 6th. The company reported $0.29 earnings per share for the quarter, beating analysts' consensus estimates of $0.21 by $0.08. Ardent Health had a net margin of 3.73% and a return on equity of 16.07%. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. On average, analysts expect Ardent Health to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ardent Health Stock Down 2.7%

Shares of ARDT traded down $0.29 during trading hours on Friday, reaching $10.31. 154,409 shares of the stock traded hands, compared to its average volume of 398,147. The company has a current ratio of 2.12, a quick ratio of 1.98 and a debt-to-equity ratio of 0.70. The stock has a fifty day simple moving average of $13.21 and a 200 day simple moving average of $13.64. Ardent Health has a 52 week low of $10.10 and a 52 week high of $20.72. The company has a market cap of $1.47 billion and a price-to-earnings ratio of 6.34.

Wall Street Analyst Weigh In

ARDT has been the topic of a number of recent analyst reports. Stephens reissued an "overweight" rating and set a $21.00 price target on shares of Ardent Health in a research report on Tuesday, May 20th. Royal Bank Of Canada reaffirmed an "outperform" rating and issued a $21.00 price objective on shares of Ardent Health in a research report on Thursday, May 15th. Wall Street Zen lowered shares of Ardent Health from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 12th. Mizuho lowered their price objective on shares of Ardent Health from $19.00 to $18.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 9th. Finally, Guggenheim lifted their price objective on shares of Ardent Health from $16.00 to $18.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, ten have issued a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $20.30.

Institutional Trading of Ardent Health

Several hedge funds and other institutional investors have recently modified their holdings of ARDT. Goldman Sachs Group Inc. raised its position in shares of Ardent Health by 1,684.9% in the first quarter. Goldman Sachs Group Inc. now owns 767,862 shares of the company's stock valued at $10,558,000 after purchasing an additional 724,841 shares during the period. Jane Street Group LLC raised its position in shares of Ardent Health by 235.1% in the first quarter. Jane Street Group LLC now owns 57,468 shares of the company's stock valued at $790,000 after purchasing an additional 40,318 shares during the period. Acadian Asset Management LLC grew its stake in Ardent Health by 574.9% during the first quarter. Acadian Asset Management LLC now owns 40,238 shares of the company's stock valued at $550,000 after acquiring an additional 34,276 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Ardent Health by 103.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company's stock valued at $194,000 after acquiring an additional 7,182 shares in the last quarter.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.